# Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation

> **NCT07426640** · NA · COMPLETED · sponsor: **Al Mouwasat Hospital** · enrollment: 150 (actual)

## Conditions studied

- Premature (Early) Ejaculation

## Interventions

- **DRUG:** BoNT-A
- **DRUG:** Placebo injection (normal saline)

## Key facts

- **NCT ID:** NCT07426640
- **Lead sponsor:** Al Mouwasat Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07426640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07426640, "Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07426640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*